Home › Non-Muscle Invasive Bladder Cancer › North Carolina › Durham
Non-Muscle Invasive Bladder Cancer clinical trials in Durham, NC
5 studies for Non-Muscle Invasive Bladder Cancer are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer
RecruitingPhase 2
- Duke Cancer Institute, Durham
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer
RecruitingPhase 1
- Biorepository and Precision Pathology Center (BRPC), Durham
- Duke Cancer Institute, Durham
- Substrate Services Core Research Support (SSCRS), Durham
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
RecruitingPhase 1
- University of North Carolina (UNC) - Chapel Hill, Chapel Hill · 10 mi away
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
RecruitingPhase 1/2
- Duke Health - Duke Cancer Center, Durham
- UNC Chapel Hill Hospital, Chapel Hill · 10 mi away
Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2
RecruitingObservational study
- University of North Carolina, Chapel Hill · 10 mi away
Non-Muscle Invasive Bladder Cancer trials in other cities
- Columbus, OH10 studies
- Dallas, TX10 studies
- New York City, NY10 studies
- Myrtle Beach, SC9 studies
- Edison, NJ9 studies
- Baltimore, MD8 studies
- Syracuse, NY8 studies
- Nashville, TN8 studies
- Houston, TX7 studies
- Indianapolis, IN7 studies
- Birmingham, AL7 studies
- Philadelphia, PA7 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.